American Action Forum Issues Commentary: Patent Cliff and the Drug Market's Innovation Cycle
August 05, 2026
August 05, 2026
WASHINGTON, Aug. 5 -- The American Action Forum issued the following commentary on Aug. 4, 2026, by Health Care Policy Director Michael Baker:
* * *
The Patent Cliff and the Drug Market's Innovation Cycle
Executive Summary
* The U.S. biopharmaceutical market has strong, structural incentives to innovate new products, anchored by robust intellectual property (IP) protections; these IP protections, however, can occasionally create windows w . . .
* * *
The Patent Cliff and the Drug Market's Innovation Cycle
Executive Summary
* The U.S. biopharmaceutical market has strong, structural incentives to innovate new products, anchored by robust intellectual property (IP) protections; these IP protections, however, can occasionally create windows w . . .